DK3995135T3 - Doseringsform med forlænget afgivelse af et salt af tapentadol med l-(+)-vinsyre - Google Patents
Doseringsform med forlænget afgivelse af et salt af tapentadol med l-(+)-vinsyre Download PDFInfo
- Publication number
- DK3995135T3 DK3995135T3 DK20206800.3T DK20206800T DK3995135T3 DK 3995135 T3 DK3995135 T3 DK 3995135T3 DK 20206800 T DK20206800 T DK 20206800T DK 3995135 T3 DK3995135 T3 DK 3995135T3
- Authority
- DK
- Denmark
- Prior art keywords
- tapentadol
- salt
- dosage form
- tartaric acid
- extended release
- Prior art date
Links
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 title 1
- 235000011002 L(+)-tartaric acid Nutrition 0.000 title 1
- 239000001358 L(+)-tartaric acid Substances 0.000 title 1
- FEWJPZIEWOKRBE-LWMBPPNESA-N L-(+)-Tartaric acid Natural products OC(=O)[C@@H](O)[C@H](O)C(O)=O FEWJPZIEWOKRBE-LWMBPPNESA-N 0.000 title 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 title 1
- 239000002552 dosage form Substances 0.000 title 1
- 238000013265 extended release Methods 0.000 title 1
- 150000003839 salts Chemical class 0.000 title 1
- KWTWDQCKEHXFFR-SMDDNHRTSA-N tapentadol Chemical compound CN(C)C[C@H](C)[C@@H](CC)C1=CC=CC(O)=C1 KWTWDQCKEHXFFR-SMDDNHRTSA-N 0.000 title 1
- 229960005126 tapentadol Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Emergency Medicine (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP20206800.3A EP3995135B1 (de) | 2020-11-10 | 2020-11-10 | Darreichungsformen mit verlängerter freisetzung eines salzes von tapentadol mit l-(+)-weinsäure |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3995135T3 true DK3995135T3 (da) | 2022-08-22 |
Family
ID=73343829
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK20206800.3T DK3995135T3 (da) | 2020-11-10 | 2020-11-10 | Doseringsform med forlænget afgivelse af et salt af tapentadol med l-(+)-vinsyre |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP3995135B1 (da) |
| AU (1) | AU2021201353B1 (da) |
| DK (1) | DK3995135T3 (da) |
| ES (1) | ES2927147T3 (da) |
| HR (1) | HRP20221136T1 (da) |
| HU (1) | HUE059465T2 (da) |
| LT (1) | LT3995135T (da) |
| PL (1) | PL3995135T3 (da) |
| PT (1) | PT3995135T (da) |
| RS (1) | RS63521B1 (da) |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4426245A1 (de) | 1994-07-23 | 1996-02-22 | Gruenenthal Gmbh | 1-Phenyl-3-dimethylamino-propanverbindungen mit pharmakologischer Wirkung |
| PE20030527A1 (es) | 2001-10-24 | 2003-07-26 | Gruenenthal Chemie | Formulacion farmaceutica con liberacion retardada que contiene 3-(3-dimetilamino-1-etil-2-metil-propil) fenol o una sal farmaceuticamente aceptable del mismo y tabletas para administracion oral que la contienen |
| JP5700904B2 (ja) | 2004-07-01 | 2015-04-15 | グリューネンタール・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング | （１ｒ，２ｒ）−３−（３−ジメチルアミノ−１−エチル−２−メチル−プロピル）フェノールを含有する乱用防止経口投与形態物 |
| KR20090074263A (ko) | 2006-10-27 | 2009-07-06 | 얀센 파마슈티카 엔.브이. | 건식 과립화 약제학적 조성물 및 이의 제조방법 |
| DE102007019417A1 (de) | 2007-04-23 | 2008-11-13 | Grünenthal GmbH | Tapentadol zur Schmerzbehandlung bei Arthrose |
| US8383152B2 (en) | 2008-01-25 | 2013-02-26 | Gruenenthal Gmbh | Pharmaceutical dosage form |
| MX341072B (es) | 2010-07-23 | 2016-08-05 | Grünenthal Gmbh * | Sales o co-cristales de 3-(3-dimetilamino-1-etil-2-metil-propil)-f enol. |
| WO2015014980A1 (en) | 2013-08-02 | 2015-02-05 | Ratiopharm Gmbh | Composition comprising tapentadol in a dissolved form |
| EP3122336A4 (en) * | 2014-03-26 | 2017-10-25 | Sun Pharma Advanced Research Company Ltd | Abuse deterrent immediate release biphasic matrix solid dosage form |
| US10182992B2 (en) * | 2014-04-07 | 2019-01-22 | Patheon Softgels Inc. | Abuse-deterrent controlled release formulations |
| EP2942054A1 (en) | 2014-05-09 | 2015-11-11 | G.L. Pharma GmbH | Slow-release pharmaceutical formulation |
| WO2017085734A1 (en) | 2015-11-17 | 2017-05-26 | Msn Laboratories Private Limited | Crystalline forms of tapentadol salts and process for preparation thereof |
| US20180369151A1 (en) * | 2017-05-29 | 2018-12-27 | Grünenthal GmbH | Multiparticulate oral dosage form providing prolonged release of tapentadol |
| CN111346077B (zh) * | 2018-12-21 | 2022-06-10 | 宜昌人福药业有限责任公司 | 一种他喷他多透皮给药的药物组合物及其制备方法和应用 |
| EP3875080A1 (en) * | 2020-03-02 | 2021-09-08 | Grünenthal GmbH | Dosage form providing prolonged release of tapentadol phosphoric acid salt |
-
2020
- 2020-11-10 HU HUE20206800A patent/HUE059465T2/hu unknown
- 2020-11-10 PL PL20206800.3T patent/PL3995135T3/pl unknown
- 2020-11-10 HR HRP20221136TT patent/HRP20221136T1/hr unknown
- 2020-11-10 EP EP20206800.3A patent/EP3995135B1/de active Active
- 2020-11-10 RS RS20220798A patent/RS63521B1/sr unknown
- 2020-11-10 ES ES20206800T patent/ES2927147T3/es active Active
- 2020-11-10 PT PT202068003T patent/PT3995135T/pt unknown
- 2020-11-10 DK DK20206800.3T patent/DK3995135T3/da active
- 2020-11-10 LT LTEP20206800.3T patent/LT3995135T/lt unknown
-
2021
- 2021-03-02 AU AU2021201353A patent/AU2021201353B1/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| HRP20221136T1 (hr) | 2022-11-25 |
| HUE059465T2 (hu) | 2022-11-28 |
| EP3995135A1 (de) | 2022-05-11 |
| LT3995135T (lt) | 2022-08-25 |
| PL3995135T3 (pl) | 2022-10-03 |
| EP3995135B1 (de) | 2022-07-13 |
| RS63521B1 (sr) | 2022-09-30 |
| AU2021201353B1 (en) | 2022-04-21 |
| ES2927147T3 (es) | 2022-11-02 |
| PT3995135T (pt) | 2022-09-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL288997A (en) | Salt forms of bempedoic acid and methods for using the same | |
| EP4083038A4 (en) | PYRIDAZINYL THIAZOLECARBOXAMIDE COMPOUND | |
| PL3720838T3 (pl) | Sole organicznych kwasów sulfonowych i estrów aminokwasów i sposoby ich wytwarzania | |
| EP2897615A4 (en) | PHARMACOKINETIC FORMULATIONS OF DEUTERATED BENZOCHINOL INHIBITORS OF THE VESICLE MONOAMINE TRANSPORTER 2 | |
| DK3976581T3 (da) | Tartaric acid salts of [2-(3-fluoro-5-methane-sulfonylphenoxy)ethyl](propyl)amine | |
| DK2717692T3 (da) | Tetrahydrocannabinol-11-syrer til anvendelse til behandling af fibrotiske sygdomme | |
| EP2757093A4 (en) | GUANIDINOBENZOESÄUREVERBINDUNG | |
| DK4313945T3 (da) | Krystallinsk hydrobromidsalt af 5-MeO-DMT | |
| EP4073036C0 (en) | CRYSTAL FORM OF A 7H-BENZO[7]ANNULENE-2-CARBOXYLIC ACID DERIVATIVE | |
| DK2561753T3 (da) | Vandigt suspensionskoncentrat omfattende et surt salt af dodecylguanidin | |
| DK3995135T3 (da) | Doseringsform med forlænget afgivelse af et salt af tapentadol med l-(+)-vinsyre | |
| CO2020001807A2 (es) | Inhibidores de rorγ | |
| EP3784222A4 (en) | Small molecule targeted recruitment of a nuclease to rna | |
| DK2561876T3 (da) | Formuleringer af deoxycholsyre og salte deraf | |
| IL305851A (en) | Preparation of 2-chloro-4-fluoro-5-nitrobenzoic acid | |
| DK4132909T3 (da) | Organiske syreadditionssalte af S-pindolol | |
| EP3305768A4 (en) | SODIUM SALT OF HARNIC ACID TRANSPORTERMER AND CRYSTALLINE FORM THEREOF | |
| EP3798305A4 (en) | MAGNET-BASED BIOPANNING PROCESS BY ATTACHING A MAGNETIC BEAD TO A CELL | |
| EP3741764A4 (en) | SYNTHESIS OF BORONIC ACID ESTER COMPOUND, AND SODIUM SALT OF BORONIC ACID ESTER COMPOUND, AND PROCESS FOR SYNTHESIS | |
| EP3854786A4 (en) | PROCESS FOR THE PREPARATION OF AMINO ACID DERIVATIVES | |
| EP3672972A4 (en) | SALT OF A COMPOUND AND CRYSTALLINE FORMS OF IT | |
| IL286692A (en) | Crystal form of acid addition salt of furopyrimidine compound | |
| EP3875077C0 (en) | TAPENTADOL PHOSPHORIC ACID SALT SUSTAINED RELEASE DOSAGE FORM | |
| EP2670707A4 (fr) | Production d'un sel cristallisé de nickel à partir de plantes hyperaccumulatrices | |
| DK2528599T3 (da) | Ny polymorf af hydrochloridet af (4-hydroxycarbamoyl-phenyl)carbaminsyren (6-dimethylamino-methyl-2-naphthalenyl)ester |